195 related articles for article (PubMed ID: 15370245)
1. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients.
Matutes E; Parry-Jones N; Brito-Babapulle V; Wotherspoon A; Morilla R; Atkinson S; Elnenaei MO; Jain P; Giustolisi GM; A'Hern RP; Catovsky D
Leuk Lymphoma; 2004 Oct; 45(10):2007-15. PubMed ID: 15370245
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
Asaad NY; Abd El-Wahed MM; Dawoud MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
[TBL] [Abstract][Full Text] [Related]
3. The splenic form of mantle cell lymphoma.
Angelopoulou MK; Siakantariz MP; Vassilakopoulos TP; Kontopidou FN; Rassidakis GZ; Dimopoulou MN; Kittas C; Pangalis GA
Eur J Haematol; 2002 Jan; 68(1):12-21. PubMed ID: 11952817
[TBL] [Abstract][Full Text] [Related]
4. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Dunphy CH; Perkins SL
Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
[TBL] [Abstract][Full Text] [Related]
5. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
[TBL] [Abstract][Full Text] [Related]
6. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract][Full Text] [Related]
7. Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome.
Molina TJ; Delmer A; Cymbalista F; Le Tourneau A; Perrot JY; Ramond S; Marie JP; Audouin J; Zittoun R; Diebold J
Virchows Arch; 2000 Dec; 437(6):591-8. PubMed ID: 11193469
[TBL] [Abstract][Full Text] [Related]
8. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease.
DiRaimondo F; Albitar M; Huh Y; O'Brien S; Montillo M; Tedeschi A; Kantarjian H; Lerner S; Giustolisi R; Keating M
Cancer; 2002 Mar; 94(6):1721-30. PubMed ID: 11920534
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma.
Todorovic M; Pavlovic M; Balint B; Kraguljac N; Mihaljevic B; Bogdanovic A; Elezovic I; Boskovic D; Colovic M
Med Oncol; 2007; 24(4):413-8. PubMed ID: 17917091
[TBL] [Abstract][Full Text] [Related]
10. A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma.
Medd PG; Clark N; Leyden K; Turner S; Strefford JA; Butler C; Collins GP; Roberts DJ; Atoyebi W; Hatton CS
Cytometry B Clin Cytom; 2011; 80(4):230-7. PubMed ID: 21462308
[TBL] [Abstract][Full Text] [Related]
11. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.
Ondrejka SL; Lai R; Smith SD; Hsi ED
Haematologica; 2011 Aug; 96(8):1121-7. PubMed ID: 21508124
[TBL] [Abstract][Full Text] [Related]
12. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract][Full Text] [Related]
13. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S
Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493
[TBL] [Abstract][Full Text] [Related]
14. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
15. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
Fang H; Medeiros LJ; Tang Z; Wang W; Ok CY; Patel KP; Khoury JD; Thakral B
Ann Diagn Pathol; 2021 Feb; 50():151649. PubMed ID: 33189964
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cyclin D1 expression by quantitative real-time reverse transcription-polymerase chain reaction in the diagnosis of mantle cell lymphoma.
Peghini PE; Fehr J
Am J Clin Pathol; 2002 Feb; 117(2):237-45. PubMed ID: 11863220
[TBL] [Abstract][Full Text] [Related]
17. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):763-768. PubMed ID: 30317731
[No Abstract] [Full Text] [Related]
19. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
20. CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.
Miao Y; Lin P; Saksena A; Xu J; Wang M; Romaguera J; Yin CC; Medeiros LJ; Li S
Am J Surg Pathol; 2019 Aug; 43(8):1052-1060. PubMed ID: 31045891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
